BamSEC and AlphaSense Join Forces
Learn More

Lisata Therapeutics Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: LSTA    
Share price (3/27/26): $5.02    
Market cap (3/27/26): $45.3 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.3
from 8-K 17 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.2
from 8-K 23 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 8-K 91 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 8-K 10 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.4
from 8-K 7 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.3
from 8-K 10 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.2
from 8-K 10 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 8-K 101 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 8-K 94 pages Interest Purchase Agreement Among Hitachi Chemical Co. America, Ltd., Pct, LLC, a Caladrius Company, and Caladrius Biosciences, Inc., Dated as of March 16, 2017 – 1 –
12/34/56
EX-2.1
from 8-K 94 pages Interest Purchase Agreement Among Hitachi Chemical Co. America, Ltd., Pct, LLC, a Caladrius Company, and Caladrius Biosciences, Inc., Dated as of March 16, 2017 – 1 –
12/34/56
EX-2.1
from DEFA14A 94 pages Interest Purchase Agreement Among Hitachi Chemical Co. America, Ltd., Pct, LLC, a Caladrius Company, and Caladrius Biosciences, Inc., Dated as of March 16, 2017 – 1 –
12/34/56
EX-2.1
from DEFA14A 94 pages Interest Purchase Agreement Among Hitachi Chemical Co. America, Ltd., Pct, LLC, a Caladrius Company, and Caladrius Biosciences, Inc., Dated as of March 16, 2017 – 1 –
12/34/56
EX-2.1
from 8-K 84 pages Agreement and Plan of Merger Between Neostem, Inc., NBS Acquisition Sub I, Inc., NBS Acquisition Sub II, LLC, California Stem Cell, Inc., and Jason Livingston as the Csc Representative
12/34/56
EX-2.1
from 8-K 5 pages Amendment to Equity Purchase Agreement
12/34/56
EX-2.1
from DEFA14A 30 pages Equity Purchase Agreement
12/34/56
EX-2.1
from 8-K 30 pages Equity Purchase Agreement
12/34/56
EX-2.1
from 8-K 133 pages Agreement and Plan of Merger Between Neostem, Inc., Amo Acquisition Company I, Inc., Amo Acquisition Company II, LLC, and Amorcyte, Inc., Dated as of July 13, 2011
12/34/56
EX-2.1
from 425 133 pages Agreement and Plan of Merger Between Neostem, Inc., Amo Acquisition Company I, Inc., Amo Acquisition Company II, LLC, and Amorcyte, Inc., Dated as of July 13, 2011
12/34/56
EX-2.1
from 8-K 109 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 425 109 pages Agreement and Plan of Merger
12/34/56